Antigenic preparations

Details Antigenic preparations Antigenic preparations

2006-08-15

2006-08-15

Prats, Francisco C. (Department: 1651)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fungus, except allergen, or component thereof or substance...

C424S275100, C435S254100, C435S255400, C435S911000, C435S922000, C514S008100, C514S054000

Reexamination Certificate

active

07090857

ABSTRACT:
The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, process for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.

REFERENCES:
patent: 3867555 (1975-02-01), Newell et al.
patent: 4146706 (1979-03-01), Hisatsuka et al.
patent: 4368191 (1983-01-01), Sarkisov et al.
patent: 4678748 (1987-07-01), Sutka et al.
patent: 5277904 (1994-01-01), Pier
patent: 6379678 (2002-04-01), Farnow et al.
patent: 0 477 231 (1995-05-01), None
patent: 0 834 322 (1998-04-01), None
patent: 1 570 538 (1980-07-01), None
patent: 2 020 959 (1994-10-01), None
patent: WO 90/15878 (1990-12-01), None
patent: WO 91/07091 (1991-05-01), None
patent: WO 93/07894 (1993-04-01), None
patent: WO 95/05400 (1995-02-01), None
patent: WO 95/26362 (1995-10-01), None
Guarro et al, Mycopathologia 122:69-77 (1993).
Jimenez-Barbero et al, Carb. Res. 272:121-128 (1995).
Kawarasaki et al, Chem. Pharm. Bull. 27(9):2073-2075 (1979).
Kitazima et al, Arch. Biochem. Biophys. 152:811-820 (1972).
Aoki, Y., and Marcus, S., “The immunologically active substances in fungi. II. The immunological activity, especially skin-test activity, of Candida antigens,”Chemical Abstracts69:8969, Abstract No. 8973q, The American Chemical Society (1968).
Askenase, P.W., “Cutaneous Basophil Hypersensitivity in Contact-Sensitized Guinea Pigs. I. Transfer with Immune Serum,”J. Exp. Med. 138:1144-1155, The Rockefeller University Press (1973).
Bishop, C.T., et al., “The Water-Soluble Polysaccharides of Dermatophytes. I. A Galactomannan from Trichophyton granulosum,”Can. J. Chem. 40:1816-1825, Ottawa National Research Council of Canada (1962).
Bishop, C.T., et al., “The Water-Soluble Polysaccharides of Dermatophytes. IV. Galactomannans I from Trichophyton granulosum, Trichophyton interdigitale, Microsporum quinckeanum, Trichophyton rubrum, and Trichophyton schönleinii,”Can. J. Chem. 43:30-39, Ottawa National Research Council of Canada (1965).
Boehncke, W.-H., et al., “Evidence for a Pathway Independent from 2'- Deoxyguanosine and Reversible by IL-2 by which Purine Nucleoside Phosphorylase Inhibitors Block T-Cell Proliferation,”Scand. J. Immunol. 39:327-332, Blackwell Scientific Publication (Mar. 1994).
Boukamp, P., et al., “Normal Keratinization in a Spontaneously Immortalized Aneuploid Human Keratinocyte Cell Line,”J. Cell Biol. 106:761-771, The Rockefeller University Press (1988).
Boukamp, P., et al., “Progressive Stages of ‘Transdifferentiation’ from Epidermal to Mesenchymal Phenotype Induced by MyoD1 Transfection, 5-aza-2'—deoxycytidine Treatmeant, and Selection for Reduced Cell Attachment in the Human Keratinocyte Line HaCat,”J. Cell Biol. 116:1257-1271, The Rockefeller University Press (1992).
Büttner, M., “Principles of Paramunization. Option and Limits in Veterinary Medicine,”Comp. Immun. Microbiol. Infect. Dis. 16:1-10, Pergamon Press, Ltd. (1993).
Gad, S.C., et al., “Development and Validation of an Alternative Dermal Sensitization Test: The Mouse Ear Swelling Test (MEST),”Toxicol. Appl. Pharmacol. 84:93-114, Academic Press, Inc. (1986).
Golub, E.S., “Hypersensitivity,”Immunology: A Synthesis, Sinauer Associates, Inc., Sunderland, MA, pp. 461-479 (1987).
Grappel, S.F., et al., “Immunological Studies on Dermatophytes. IV. Chemical Structures and Serological Reactivities of Polysaccharides fromMicrosporum praecox, Trichophyton ferrugineum, Trichophyton sabouraudii, andTrichophyton tonsurans,”J. Bacteriol. 97: 23-26, American Society for Microbiology (1969).
Green III, F., and Balish, E., “Suppression of In Vitro Lymphocyte Transformation During an Experimental Dermatophyte Infection,”Infect. Immun. 26:554-562, American Society for Microbiology (1979).
Green III, F., et al., “Cutaneous Basophil Hypersensitivity and Contact Sensitivity After CutaneousTrichophyton mentagrophytesInfection,”Infect. Immun. 29:758-767, American Society for Microbiology (1980).
Green III, F., and Balish, E., “Trichophyton mentagrophytesDermatophytosis in Germfree Guinea Pigs,”J. Invest. Dermatol. 75:476-480, The Williams & Wilkins Co. (1980).
Ryle, C.M., et al., “Density-dependent modulation of synthesis of keratins 1 and 10 in the human keratinocyte line HACAT and inras-transfected tumorigenic clones,”Differentiation 40:42-54, Springer-Verlag (1989).
Strube, W., et al., “Baypamun: New Possibilities for the Control of Infectious Diseases in Domestic Animals,”Vet. Med. Rev. 60:3-15, Leverkusen Farbenfabriken Bayer (1989).
Wu-Yuan, C.D., and Hashimoto, T., “Architecture and Chemistry of Microconidial Walls ofTrichophyton mentagrophytes,”J. Bacteriol. 129:1584-1592, American Society for Microbiology (1977).
International Search Report for International Application No. PCT/EP96/03535 mailed on Nov. 18, 1996.
Dialog File 351, Accession No. 9458658, Derwent WPI English language abstract for WO 93/07894 and RU 2 020 959.

Affiliated with

Also associated with

Rating

Antigenic preparations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antigenic preparations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antigenic preparations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3701942